| Financial Year |
March 31 2023 |
| Monetary Funds |
540,962,424.07 |
| Held-for-trading Financial Assets |
50,205,687.82 |
| Notes Receivable |
4,000,000.00 |
| Accounts Receivable |
657,392,996.06 |
| Advances to Suppliers |
123,697,235.37 |
| Other Receivables |
47,321,756.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
443,369,311.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,200,125.94 |
| Total Current Assets |
2,231,471,586.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,970,166.63 |
| Investment Properties |
6,072,805.64 |
| Fixed Assetes |
405,601,192.06 |
| Under-construction Projects |
304,920,926.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,427,615.19 |
| R&D expenses |
8,359,752.79 |
| Goodwill |
288,832,665.62 |
| Long-Term Deferred and Prepaid Expenses |
6,669,913.34 |
| Deferred Income Tax Assets |
28,096,282.24 |
| Other Non-Current Assets |
41,826,737.93 |
| Sub-Total of Non-Current Assets |
1,260,436,348.16 |
| Total Assets |
3,491,907,934.47 |
| Short-Term Loans |
215,849,333.14 |
| Trading Financial liabilities |
-- |
| Notes Payable |
141,238,364.46 |
| Accounts Payable |
483,251,336.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,853,579.95 |
| Taxes Payable |
17,946,197.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,946,662.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
56,734,197.53 |
| Other Current Liabilities |
34,151,063.53 |
| Sub-Total of Current Liabilities |
1,203,871,258.79 |
| Long-term Loans |
48,800,000.00 |
| Bonds Payable |
488,469,370.98 |
| Long-Term Accounts Payable |
33,724,319.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,031,735.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
617,725,902.81 |
| Total Liabilities |
1,821,597,161.60 |
| Paid-In Capital(Or Share Stock) |
406,509,381.00 |
| Capital Surplus |
612,020,009.98 |
| Surplus Reserve |
54,461,438.08 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
528,604,807.72 |
| Minority Stockholder's Interest |
1,569,841.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,668,740,931.59 |
| Owner's Equity（Stockholder's Equity） |
1,670,310,772.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,491,907,934.47 |
